REPORTED BY
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
OR SEND
$150 DOLLARS TO CASH APP:$docnorm
“WE ARE NOT POWERLESS, AND THROUGH OUR VIDEOS, WRITINGS, AND PHOTOGRAPHS WE WILL EXPOSE THE ABUSES AND TYRANNY JUST AS THE VIDEO WAS RECORDED BY THE CELL PHONE CAMERA OF YOUNG DARNELLA FRAZIER, BORE WITNESS TO THE MURDER OF GEORGE FLOYD THE BLOG youarewithinthenorms.com BARES WITNESS AND BOTH ALLOWS THE SYSTEM TO BE HELD ACCOUNTABLE”
“WE ARE HEALTHCARE PROVIDERS, NOT STREET DRUG DEALERS“
ARTICLE BY
WALTER F. WRENN III., MD
EXAMINING THE CAUSE OF OVERDOSE DEATHS
There have been many theories as to the cause of overdose deaths. Even though observational data doesn’t substitute for a clinical trial, it can be useful. In addition, because autopsy information is available, we can track the opiate found at the autopsy as well as other drugs. Therefore, I propose a study starting in 2005,2010,2015, and today.
EXAMINING THE FORENSICS
We should look at the opiate found at autopsy for these periods. We should also record the percentage of that opiate found against the total number of overdose deaths. We can then accurately determine whether the deadly triad was responsible.
Whether health care providers or pharmaceutical companies were responsible. Whether heroin or fentanyl was responsible. We even may be able to determine if the DOJ/DEA and state AG were responsible.
Based on my observations of the data, I will give you my opinion on what we will find. From 2005 until 2015, heroin was the opiate found at autopsy. From 2015 until today, fentanyl is the opiate that has been found. Also, the percentage of fentanyl overdose deaths far outpaces the percentage of heroin found at autopsy. The percentage of prescription opiate pain medication found at autopsy has not changed from 2005 to today.
OR SEND
$150 DOLLARS TO CASH APP:$docnorm
US TROOPS PROTECT POPPIES IN AFGHANISTAN
FOLLOW THE SCIENCE
The role of the “deadly triad ” has not changed since 2005. You may be wondering why I believe that a scientific review will show these results. Since 2015 fentanyl has been sold as a substitute for heroin but also for opiate pain medication and non-opiate medication such as Xanax, Adderall, and Soma.
Illicit non-medical street Fentanyl is also being mixed with and sold as cocaine, methamphetamines, and marijuana. Heroin was never sold as anything but heroin and there is no therapeutic dose.
Therefore, the percentage of overdose deaths where heroin is found hasn’t changed since 2005. I believe that this information would help all of us whether we are awaiting trial or our cases have been settled.
Walter F. Wrenn III M.D.
FOR NOW, YOU ARE WITHIN
THE NORMS
OR SEND
$150 DOLLARS TO CASH APP:$docnorm
REFERENCES:
America’s War on Drugs has played a profound role in reinforcing racial hierarchies. Although Black Americans are no more likely than Whites to use illicit drugs, they are 6–10 times more likely to be incarcerated for drug offenses. Helena B. Hansen, an assistant professor in the Department of Psychiatry at New York University, examines the recent history of White opioids to show how a very different system for responding to the drug use of Whites has emerged, in which addiction is treated primarily as a biomedical disease.
Meanwhile, more punitive systems that govern the drug use of people of color have remained intact. At this seminar, Dr. Hansen argues that public concern about White opioid deaths creates an opportunity to reorient U.S. drug policy toward public health for all—and make proven harm reduction strategies widely available.
